ASST vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits weak financial health with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to confirm solvency, raising uncertainty. Despite a strong revenue growth of 56.80% YoY and a low Price/Book of 0.74 suggesting possible value, extreme negative operating margins (-3064.29%) and a sky-high Price/Sales ratio of 197.00 signal severe profitability and valuation concerns. The stock has lost over 95% of its value in the past five years, with a current technical trend scoring 0/100, reflecting deep investor skepticism. While the balance sheet shows no debt and high liquidity ratios, these positives are overshadowed by absent profitability, lack of earnings, and minimal analyst coverage.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
ASST vs JPM: Head-to-Head Comparison
This page compares Strive Asset Management, LLC (ASST) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.